Multiple Choice
How does onabotulinumtoxinA (BOTOX) therapeutically produce paresis in overactive muscles?
A) Acts as an antagonist by binding to the ACh receptor on the postsynaptic membrane.
B) Rapidly degrades ACh in the synaptic cleft.
C) Facilitates the reuptake and sequestration of ACh into the presynaptic cell.
D) Disrupts the protein structure of the muscle cell receptor,thus preventing ACh from binding.
E) Inhibits the release of ACh from the presynaptic terminal at the neuromuscular junction.
Correct Answer:

Verified
Correct Answer:
Verified
Q1: ACh receptor subtypes include:<br>A)Adrenergic and noradrenergic<br>B)Nicotinic and
Q2: Which one of the following is used
Q3: N-methyl-D-aspartate (NMDA)receptors:<br>A)Are involved in long-term potentiation.<br>B)Bind glutamate.<br>C)Have
Q4: Which one of the following can serve
Q6: Second messengers may initiate the:<br>A)Opening of membrane
Q7: Which of the following is a type
Q8: An antagonist drug acts by:<br>A)Preventing the release
Q9: Which of the following neurotransmitters is paired
Q10: Which of the following neurotransmitters and modulators
Q11: When an action potential arrives at the